FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

SCA Pharmaceuticals Buffered Lidocaine 1% with Sodium Recall

Buffered Lidocaine 1% with Sodium Bicarbonate Injection for Local Anesthetic Use (Conce…

SCA Pharmaceuticals · Little Rock, AR

Risk level
Class II
Reported by FDA
Jul 18, 2018
Recall ID
D-0918-2018
Check your lot numberHow we source this data

Summary

SCA Pharmaceuticals recalled Buffered Lidocaine 1% with Sodium starting Jun 29, 2018. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0918-2018 on Jul 18, 2018. Reason: Subpotent Drug: Stability data does not support the current expiration dating of 55 days after compounding. Status: Terminated.

Why it was recalled

Subpotent Drug: Stability data does not support the current expiration dating of 55 days after compounding.

Product description

Buffered Lidocaine 1% with Sodium Bicarbonate Injection for Local Anesthetic Use (Concentration=10 mg/mL) 0.25 mL Total Volume, Rx only , SCA Pharmaceuticals, 8821 Knoedl Ct. Little Rock, AR 72205 877-550-5059

Lot numbers, UPCs & expiration codes

Lot #: 20180507@21, Exp 7/1/2018; 20180511@9, 20180511@24, Exp 7/5/2018; 20180518@24, 20180518@31, 20180518@32, Exp 7/12/2018; 20180531@21, Exp 7/25/2018; 20180601@11, Exp 7/26/2018

Where it was sold

United States

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0918-2018
Classification
Class II
Status
Terminated
Recall initiated
Jun 29, 2018
FDA report date
Jul 18, 2018
Quantity
3984 syringes
Recall type
Voluntary: Firm initiated
Recalling firm
SCA Pharmaceuticals

Original FDA data

Every field from FDA enforcement report D-0918-2018, exactly as published.

Show all FDA fields
City
Little Rock
State
AR
Status
Terminated
Country
United States
Event ID
80425
Address
8821 Knoedl Ct
Code information
Lot #: 20180507@21, Exp 7/1/2018; 20180511@9, 20180511@24, Exp 7/5/2018; 20180518@24, 20180518@31, 20180518@32, Exp 7/12/2018; 20180531@21, Exp 7/25/2018; 20180601@11, Exp 7/26/2018
Postal code
72205-4600
Report date
Jul 18, 2018
Product type
Drugs
Recall number
D-0918-2018
Classification
Class II
Recalling firm
SCA Pharmaceuticals
Product quantity
3984 syringes
Termination date
May 1, 2019
Reason for recall
Subpotent Drug: Stability data does not support the current expiration dating of 55 days after compounding.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Buffered Lidocaine 1% with Sodium Bicarbonate Injection for Local Anesthetic Use (Concentration=10 mg/mL) 0.25 mL Total Volume, Rx only , SCA Pharmaceuticals, 8821 Knoedl Ct. Little Rock, AR 72205 877-550-5059
Distribution pattern
United States
Recall initiation date
Jun 29, 2018
Initial firm notification
Letter
Center classification date
Jul 12, 2018

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0918-2018, published Jul 18, 2018. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls